IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials By Steve|2024-10-14T16:43:27+13:00September 25th, 2024|Categories: All, Q&A, Z-Legacy|Tags: ATR Inhibitors, clinical, Clinical Trial, iCCA, IDH1 Mutation, PARP Inhibitors, RAD-3, Shruti| Read More 0